The role of the scavenger receptor CD36 in regulating mononuclear phagocyte trafficking to atherosclerotic lesions and vascular inflammation
Authors:
Open Access
- 5 March 2009
- journal article
- research article
- Published by Oxford University Press (OUP) in Cardiovascular Research
- Vol. 83 (1) , 42-51
Abstract
CD36 has been shown to associate with non-receptor Src kinases to activate mitogen-activated protein kinases and trigger cytoskeletal remodelling, important events in foam cell formation and macrophage migration. Yet, its role in regulating circulating mononuclear phagocyte trafficking to atherosclerotic lesions has not been investigated. The aim of the present study was to investigate the role of CD36 in modulating the recruitment of mononuclear phagocytes to the arterial wall and the associated vascular inflammation, using both pharmacological and genetic approaches. Apolipoprotein E-deficient (apoE−/−) mice fed a high-fat, high-cholesterol diet were treated daily with a CD36 ligand, EP 80317 (300 µg/kg), or 0.9% NaCl for 6 or 12 weeks. Forty-eight hours before sacrifice, mice were injected iv with 111Indium-labelled macrophages. A 65% (P < 0.001) reduction of labelled macrophage accumulation at aortic lesions was observed in EP 80317-treated mice, mainly at the level of the aortic arch and iliac arteries, correlating with a 43% reduction of atherosclerotic lesion areas. This was associated with reduced phosphorylation of the focal adhesion kinase Pyk2 following stimulation with oxidized phospholipid in a Src kinase- and CD36-dependent manner. At the vascular level, EP 80317 treatment reduced the expression of pro-inflammatory proteins, including NADPH oxidase, inducible nitric oxide synthase, vascular endothelial cell adhesion molecule-1, and CCL2 chemokine. Plasma IL-6 levels were also reduced by 40% (P < 0.05). In contrast, none of these proteins was modulated in EP 80317-treated apoE/CD36 double knockout (apoE−/−/CD36−/−) mice. Our results support a role for CD36 signalling in the regulation of mononuclear phagocyte trafficking to atherosclerotic-prone sites and in the associated vascular wall inflammation.Keywords
This publication has 54 references indexed in Scilit:
- A Specific CD36-Dependent Signaling Pathway Is Required for Platelet Activation by Oxidized Low-Density LipoproteinCirculation Research, 2008
- Regulation of lamellipodial persistence, adhesion turnover, and motility in macrophages by focal adhesion kinaseJournal of Cell Biology, 2007
- Absence of CD36 protects against atherosclerosis in ApoE knock-out mice with no additional protection provided by absence of scavenger receptor A I/IICardiovascular Research, 2007
- A CD36-dependent signaling cascade is necessary for macrophage foam cell formationCell Metabolism, 2006
- Monocyte accumulation in mouse atherogenesis is progressive and proportional to extent of diseaseProceedings of the National Academy of Sciences, 2006
- Response to Staphylococcus aureus requires CD36-mediated phagocytosis triggered by the COOH-terminal cytoplasmic domainJournal of Cell Biology, 2005
- A Role for Oxidized Phospholipids in AtherosclerosisNew England Journal of Medicine, 2005
- CD36 is a sensor of diacylglyceridesNature, 2005
- Multifunctional roles of macrophages in the development and progression of atherosclerosis in humans and experimental animalsMedical Molecular Morphology, 2002
- Fate of mouse macrophages radiolabelled with PKH-95 and injected intravenouslyNuclear Medicine and Biology, 1995